vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and FGI Industries Ltd. (FGI). Click either name above to swap in a different company.
FGI Industries Ltd. is the larger business by last-quarter revenue ($30.5M vs $19.2M, roughly 1.6× Apyx Medical Corp). Apyx Medical Corp runs the higher net margin — -6.8% vs -8.6%, a 1.8% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -14.4%). FGI Industries Ltd. produced more free cash flow last quarter ($2.3M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -0.5%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
FGI Industries Ltd is a global designer, manufacturer and distributor of kitchen and bath products, home organization solutions, and home improvement goods. It serves major retail chains, home specialty stores and e-commerce platforms across North America, Europe and the Asia-Pacific region.
APYX vs FGI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $30.5M |
| Net Profit | $-1.3M | $-2.6M |
| Gross Margin | 62.6% | 26.7% |
| Operating Margin | 0.1% | -2.2% |
| Net Margin | -6.8% | -8.6% |
| Revenue YoY | 34.7% | -14.4% |
| Net Profit YoY | 71.9% | -553.1% |
| EPS (diluted) | — | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $30.5M | ||
| Q3 25 | $12.9M | $35.8M | ||
| Q2 25 | $11.4M | $31.0M | ||
| Q1 25 | $9.4M | $33.2M | ||
| Q4 24 | $14.2M | $35.6M | ||
| Q3 24 | $11.5M | $36.1M | ||
| Q2 24 | $12.1M | $29.4M | ||
| Q1 24 | $10.2M | $30.8M |
| Q4 25 | $-1.3M | $-2.6M | ||
| Q3 25 | $-2.0M | $-1.7M | ||
| Q2 25 | $-3.8M | $-1.2M | ||
| Q1 25 | $-4.2M | $-629.1K | ||
| Q4 24 | $-4.6M | $-402.3K | ||
| Q3 24 | $-4.7M | $-550.1K | ||
| Q2 24 | $-6.6M | $163.6K | ||
| Q1 24 | $-7.6M | $-412.2K |
| Q4 25 | 62.6% | 26.7% | ||
| Q3 25 | 64.4% | 26.5% | ||
| Q2 25 | 62.3% | 28.1% | ||
| Q1 25 | 60.1% | 26.8% | ||
| Q4 24 | 63.0% | 24.6% | ||
| Q3 24 | 60.5% | 25.8% | ||
| Q2 24 | 61.7% | 30.5% | ||
| Q1 24 | 58.1% | 27.4% |
| Q4 25 | 0.1% | -2.2% | ||
| Q3 25 | -6.5% | 1.0% | ||
| Q2 25 | -22.6% | -2.7% | ||
| Q1 25 | -32.4% | -3.9% | ||
| Q4 24 | -21.4% | -3.5% | ||
| Q3 24 | -31.6% | -0.2% | ||
| Q2 24 | -45.7% | -1.5% | ||
| Q1 24 | -64.6% | -1.0% |
| Q4 25 | -6.8% | -8.6% | ||
| Q3 25 | -15.4% | -4.6% | ||
| Q2 25 | -33.2% | -4.0% | ||
| Q1 25 | -44.0% | -1.9% | ||
| Q4 24 | -32.5% | -1.1% | ||
| Q3 24 | -40.9% | -1.5% | ||
| Q2 24 | -54.0% | 0.6% | ||
| Q1 24 | -74.0% | -1.3% |
| Q4 25 | — | $-1.63 | ||
| Q3 25 | — | $-0.86 | ||
| Q2 25 | — | $-0.64 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | — | $-0.38 | ||
| Q3 24 | — | $-0.29 | ||
| Q2 24 | $-0.19 | $0.08 | ||
| Q1 24 | $-0.22 | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $1.9M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $17.3M |
| Total Assets | $66.8M | $69.5M |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $1.9M | ||
| Q3 25 | $25.1M | $1.9M | ||
| Q2 25 | $29.3M | $2.5M | ||
| Q1 25 | $31.0M | $1.2M | ||
| Q4 24 | $31.7M | $4.6M | ||
| Q3 24 | $28.0M | $3.0M | ||
| Q2 24 | $32.7M | $1.3M | ||
| Q1 24 | $37.3M | $3.3M |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $17.3M | ||
| Q3 25 | $5.8M | $19.7M | ||
| Q2 25 | $7.3M | $21.3M | ||
| Q1 25 | $10.5M | $21.8M | ||
| Q4 24 | $14.2M | $22.3M | ||
| Q3 24 | $11.0M | $23.5M | ||
| Q2 24 | $14.7M | $23.8M | ||
| Q1 24 | $20.3M | $23.9M |
| Q4 25 | $66.8M | $69.5M | ||
| Q3 25 | $57.4M | $73.0M | ||
| Q2 25 | $58.2M | $71.7M | ||
| Q1 25 | $60.2M | $68.5M | ||
| Q4 24 | $64.8M | $75.5M | ||
| Q3 24 | $60.7M | $74.7M | ||
| Q2 24 | $65.4M | $69.9M | ||
| Q1 24 | $70.7M | $68.6M |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $2.3M |
| Free Cash FlowOCF − Capex | $-2.8M | $2.3M |
| FCF MarginFCF / Revenue | -14.6% | 7.5% |
| Capex IntensityCapex / Revenue | 1.4% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $-212.5K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $2.3M | ||
| Q3 25 | $-3.5M | $-1.9M | ||
| Q2 25 | $-1.2M | $7.6M | ||
| Q1 25 | $-702.0K | $-7.4M | ||
| Q4 24 | $-2.9M | $617.4K | ||
| Q3 24 | $-4.4M | $-915.0K | ||
| Q2 24 | $-4.3M | $862.1K | ||
| Q1 24 | $-6.3M | $-8.0M |
| Q4 25 | $-2.8M | $2.3M | ||
| Q3 25 | $-4.1M | $-2.1M | ||
| Q2 25 | $-1.5M | $7.4M | ||
| Q1 25 | $-757.0K | $-7.7M | ||
| Q4 24 | $-3.2M | $-214.1K | ||
| Q3 24 | $-4.6M | $-1.1M | ||
| Q2 24 | $-4.6M | $281.5K | ||
| Q1 24 | $-6.4M | $-8.6M |
| Q4 25 | -14.6% | 7.5% | ||
| Q3 25 | -31.5% | -5.9% | ||
| Q2 25 | -13.2% | 23.8% | ||
| Q1 25 | -8.0% | -23.3% | ||
| Q4 24 | -22.4% | -0.6% | ||
| Q3 24 | -40.0% | -3.0% | ||
| Q2 24 | -38.0% | 1.0% | ||
| Q1 24 | -62.2% | -28.0% |
| Q4 25 | 1.4% | 0.2% | ||
| Q3 25 | 4.0% | 0.7% | ||
| Q2 25 | 2.3% | 0.7% | ||
| Q1 25 | 0.6% | 1.1% | ||
| Q4 24 | 1.7% | 2.3% | ||
| Q3 24 | 1.3% | 0.5% | ||
| Q2 24 | 2.4% | 2.0% | ||
| Q1 24 | 0.3% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.27× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APYX
Segment breakdown not available.
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
